Autolus Therapeutics (ADR) (AUTL)
Commercializes AUCATZYL while developing programmed T-cell therapies for cancer and autoimmune diseases.
$2.10
After hours+0.06 (+2.94%)
At close$2.04(+5.15%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 49.67% | 132.21M ADS | |
|---|---|---|---|
| 86 holders · as of Jun 30, 2026 | |||
| Insiders | 0.54% | 1.43M ADS | |
| 5 holders · as of Sep 3, 2026 | |||
| Other | 49.79% | 132.53M ADS | |
| remainder | |||
266.16M ADS as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
86 holders · 132.21M shares · 10 new positions · 38 increased · 20 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Mak Capital One LLC | 33.62M | 12.63% | 0 | Aug 14, 2026 |
| Blackstone Inc. | 20.49M | 7.70% | 0 | Aug 14, 2026 |
| Syncona Portfolio Ltd | 16.64M | 6.25% | 0 | Aug 7, 2026 |
| Armistice Capital, LLC | 15.00M | 5.64% | −800.0K | Aug 14, 2026 |
| TFG Asset Management GP Ltd | 9.50M | 3.57% | 0 | Aug 13, 2026 |
| Schroder Investment Management Group | 7.83M | 2.94% | −1.66M | Aug 13, 2026 |
| Frazier Life Sciences Management, L.P. | 4.45M | 1.67% | 0 | Aug 14, 2026 |
| BNP Paribas Asset Management Holding S.A. | 3.36M | 1.26% | 0 | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| MAK Capital Fund LP | 12.60% | 33.62M | 13G | May 15, 2026 |
| Syncona Portfolio Limited | 10.80% | 28.82M | 13G | May 7, 2025 |
| Wellington Investment Advisors Holdings LLPincl. Wellington Management Company LLP, Wellington Management Group LLP +1 more | 9.11% | 24.22M | 13G | Nov 8, 2024 |
| Armistice Capital, LLC | 5.94% | 15.80M | 13G | May 15, 2026 |
| PPF IM Ltd.incl. Renata Kellnerova, PPF Group a.s. +1 more | 5.60% | 14.78M | 13D | Aug 28, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 2, 2026 | Cintia Piccinaofficer: U.S. CCO & Country Gen Manager | Sale | 6,713 | $2.34 | 13,287 |
House and Senate disclosures
Not reported.